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Objective New tobacco control policies have been
introduced in Massachusetts which restrict tobacco
product sales in pharmacies. The purpose of this
investigation was to outline the scope of pharmacy
involvement in the tobacco market by assessing the
availability and range of tobacco products sold in
Massachusetts pharmacies.
Methods Public listings of licenced pharmacies and
tobacco retailers in Massachusetts were examined to
determine the proportion of pharmacies licenced to sell
tobacco, and the proportion of tobacco retailers
possessing a pharmacy licence. Telephone interviews
were conducted with a random sample (n=70) of
pharmacies possessing a tobacco licence to assess
the availability and range of tobacco products for sale.
The availability of nicotine replacement therapy (NRT)
products was assessed as a comparison.
Results The majority of pharmacies in Massachusetts
possessed a tobacco licence (69%), and pharmacies
made up 9% of licenced tobacco retailers. Among
pharmacies surveyed that reported selling tobacco (90%),
cigarettes were the most available tobacco product for
sale (100%), followed by cigars (69%), little cigars/
cigarillos (66%), moist snuff (53%), pipe tobacco (49%),
roll-your-own tobacco (34%), snus (14%), dissolvable
tobacco (11%) and electronic cigarettes (2%). Nearly all
pharmacies selling tobacco offered the nicotine patch
(100%), gum (100%) and lozenge (98%).
Conclusions Tobacco-free pharmacy policies would
affect a majority of Massachusetts pharmacies and
remove a variety of tobacco products from their store
shelves. Further, nearly one in ten tobacco retailers
would be eliminated by prohibiting tobacco sales in
Massachusetts pharmacies statewide.
INTRODUCTION
In recent decades important changes have been
observed in the sale of tobacco products in phar-
macies. Internationally, the sale of tobacco
products in pharmacies has been eliminated in
many developed countries1 2 and Federation
Internationale Pharmaceutique, an international
pharmacists’ organisation, has lent support to
tobacco-free pharmacy policies.3 Data from devel-
oping countries are rare, but one recent study
has suggested that just 5.7% of pharmacies in
Guatemala sell tobacco products.4 Concern over
pharmacy sale of tobacco in the USA has led to
the introduction of new local tobacco control pol-
icies. In 2008, San Francisco became the first
American city to prohibit pharmacies from selling
tobacco products.5 Boston adopted a similar policy
in 2009.6 In both jurisdictions, restrictions apply
to all businesses with a pharmacy licence, includ-
ing large wholesale stores and grocery stores that
contain pharmacies. Since this time, additional
communities in Massachusetts have prohibited
tobacco sales in pharmacies, including the city of
Newton and the town of Needham (personal cor-
respondence (AS), Municipal Tobacco Control
Technical Assistance Program).
Pharmacies have been targeted for tobacco sales
restrictions due to their important role in sup-
plying health-related products and services.
Pharmacies are the leading distributors of medica-
tions used to treat and manage tobacco-related
diseases, including chronic obstructive pulmonary
disease, heart disease and nicotine dependence.7 In
2004, US expenditures for smoking-attributable
prescription drug sales totalled $15.5 billion, or
9.48% of total prescription drug sales.8 Further,
ancillary health services, including smoking cessa-
tion counselling by pharmacists or other trained
clinicians, are increasingly offered within pharma-
cies.9 10 Pharmacist-led cessation counselling has
been recognised as having many advantages,
including pharmacists’ unique expertise in drug
therapy and broad access to the public.11
The pharmacist community has held a longstand-
ing position against the sale of tobacco products in
pharmacies. In 1971, The American Pharmaceutical
Association, now the American Pharmacists
Association, passed a resolution recommending that
tobacco products not be sold in pharmacies.12 Several
state pharmacist associations have also expressed
opposition to pharmacy tobacco sales.13 14 Surveys
of pharmacists and pharmacy students reveal
discontent regarding the sale of tobacco in their
workplaces.15–18 Further, in 2010, the American
Pharmacists Association adopted a newer resolution
encouraging the government to end reimbursements
to pharmacies selling tobacco and to stop licensing
pharmacies that sell tobacco.19
Nevertheless, many American pharmacies sell
tobacco products. A 1996 national survey found
that half (50.5%) of pharmacies sold cigarettes.20
Surveys conducted in Kentucky and California
have reported between 33–61% of pharmacies sell
cigarettes.21–23 These surveys also found that
independently-owned pharmacies are less likely
than chain pharmacies to sell tobacco products.
Further, new evidence has revealed that despite a
national declining trend in total cigarette sales
in the USA, cigarette sales in pharmacies have
increased in recent years.24
As tobacco sales in pharmacies face increased
scrutiny and more communities consider restric-
tions, data on the availability and range of tobacco
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products sold in pharmacies are needed to help inform policy-
makers of the scope of pharmacy involvement in the tobacco
market. Such data may also help elucidate the potential impact
of tobacco product sales restrictions. The purpose of this inves-
tigation was to use publicly available data to determine the
proportion of pharmacies that possess a tobacco licence, the
proportion of tobacco retailers that possess a pharmacy licence
and the types of tobacco products sold in pharmacies in
Massachusetts.
METHODS
A cross-sectional, descriptive study was conducted to determine:
(i) the proportion of licenced pharmacies in Massachusetts which
also possess a licence to sell tobacco products; (ii) the proportion
of licenced tobacco retailers in Massachusetts which also possess a
pharmacy licence; and (iii) the availability (% pharmacies which
carry tobacco products) and range of tobacco products sold among
a subset of Massachusetts pharmacies. The availability of nicotine
replacement therapy (NRT) products was also determined for
comparative purposes.
Public listings of licenced retail pharmacies (n=1133) and
tobacco retailers (n=8840) in Massachusetts were obtained
from the Massachusetts Department of Public Health
and Massachusetts Department of Revenue, respectively, in
February, 2010. By March, 2010, four communities in
Massachusetts (Boston, Needham, Newton, and Uxbridge) had
adopted tobacco-free pharmacy policies (personal correspond-
ence (AS), Massachusetts Department of Public Health).
Pharmacies located within these jurisdictions (n=123) were
excluded. The two lists were compared by business address to
determine the proportion of pharmacies possessing a tobacco
licence and the proportion of tobacco retailers possessing a
pharmacy licence. All licenced pharmacies were classified
as ‘chain’ (≥5 retail stores in Massachusetts) or ‘non-chain’ (<5
retail stores in Massachusetts) pharmacies, and the proportion
of chain and non-chain pharmacies possessing a tobacco licence
were determined. χ2 test was used to test for a difference
between the proportion of chain and non-chain pharmacies
possessing a tobacco licence.
Pharmacies possessing a tobacco licence were randomly
selected for a telephone survey conducted in March–April 2010
to determine the availability of tobacco and non-prescription
NRT products. A 10% subset (n=70) was desired. Pharmacies
were randomised by the following procedure. First, all licenced
pharmacies possessing a tobacco licence were listed in an elec-
tronic spreadsheet. Next, a random number generator was used
to assign a random number to each pharmacy. The list of phar-
macies was then sorted by random number to create a list of
pharmacies in random order. Pharmacies were contacted in suc-
cessive chronological order, according to the randomised list.
Fisher ’s exact test was used to test for a difference between
the proportion of chain and non-chain pharmacies within the
sample that possess a tobacco licence. Figure 1 illustrates the
sampling strategy used.
Pharmacies were contacted via telephone. Interviewers iden-
tified themselves, stated the survey ’s purpose and nature and
invited pharmacy staff to participate. No participant incentive
was provided. Interviews were administered to store clerks,
managers or pharmacists to determine product and service
availability. The availability of the following types of tobacco
products was determined: cigarettes, cigars, little cigars/cigaril-
los (small and mid-sized cigars), pipe tobacco, moist snuff
(smokeless tobacco product typically placed between the lower
lip and gum), snus (Swedish-styled smokeless tobacco product
typically placed between the upper lip and gum), roll-your-own
tobacco (RYO; pouched tobacco used for making cigarettes by
hand or with a device), dissolvable tobacco (small tobacco
tablets that dissolve in the mouth) and electronic cigarettes
(battery powered devices that vapourise a nicotine solution
within a cartridge). Descriptions of each type of product and
examples of leading brands were provided to help respondents
distinguish between tobacco product types and quickly deter-
mine availability. The Harvard School of Public Health Office
of Human Research Administration deemed the study protocol
as exempt, and not subject to review.
RESULTS
Out of the 1133 licenced pharmacies in Massachusetts, 787 pos-
sessed a licence to sell tobacco products (69.5%). Pharmacies
with a tobacco licence represented 9% of all licenced tobacco
retailers in Massachusetts. After excluding pharmacies located
within the communities that had adopted tobacco-free phar-
macy policies, 697 pharmacies possessed a tobacco licence
(69.0%). These pharmacies represented 8% of the state’s licenced
tobacco retailers. Among the pharmacies with a tobacco licence,
80% were chain pharmacies. A significantly higher proportion of
chain pharmacies (70%) had a licence to sell tobacco products
compared with non-chain pharmacies (24%; p<0.001).
To achieve the desired sample of 70 pharmacies (10% subset
of pharmacies possessing a tobacco licence), 106 pharmacies
were contacted (66% response rate). While all pharmacies inter-
viewed by phone possessed a tobacco licence, 90% (n=63)
reported current sale of tobacco products. Within the sample,
89% (n=62) of pharmacies were chain pharmacies, 11% (n=8)
were non-chain pharmacies. Further, 97% of chain pharmacies
Figure 1 Flow diagram of pharmacy sample selection.
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reported selling tobacco products compared with 38% (ie, 3/8)
of non-chain pharmacies (p<0.001). Out of all the respon-
dents, 41.9% were pharmacists, 10.8% were pharmacy man-
agers, 11.8% were pharmacy technicians, 2.2% were pharmacy
interns, 18.3% were store clerks, 6.5% were store supervisors,
7.5% were store managers and 1.1% were store owners.
Among those pharmacies reporting tobacco product sales,
cigarettes were available for purchase in 100% of pharmacies.
Cigars were the next most available product (69%), followed
by little cigars/cigarillos (66%), moist snuff (53%), pipe tobacco
(49%), RYO tobacco (34%), snus (14%), dissolvable tobacco
(11%) and electronic cigarettes (2%).
Nicotine patch (100%), nicotine gum (100%) and nicotine
lozenge (98%) were available in nearly all pharmacies which sold
tobacco products. Figure 2 displays the availability of tobacco pro-
ducts, and NRT products among pharmacies selling tobacco.
DISCUSSION
A majority (69%) of pharmacies in Massachusetts was licenced
to sell tobacco products, and pharmacies made up 9% of
tobacco retailers. In addition, a wide variety of tobacco pro-
ducts were being sold in Massachusetts pharmacies, including
many non-cigarette products, such as cigars, little cigars/cigaril-
los, moist snuff and pipe tobacco. In recent years, sales of non-
cigarette tobacco products, including smokeless tobacco and
little cigars, have increased.25 Little cigars/cigarillos and moist
snuff were found in 66% and 53% of pharmacies, respectively.
Further, many new tobacco products have recently been intro-
duced into US markets, including snus and electronic cigarettes.
New products were sold in less than 15% of pharmacies.
Among the pharmacies contacted, 10% reported not selling
tobacco products. We excluded pharmacies located within com-
munities that, at the time of data collection, had laws prohibit-
ing pharmacy tobacco sales. Therefore, it is assumed that the
contacted pharmacies were voluntarily abstaining from tobacco
product sales, despite possessing a tobacco licence. It is possible
that some pharmacies may have elected to cease tobacco
product sales as a business decision or out of anticipation of
future sales restrictions. In California, voluntary abandonment
of tobacco products sales by pharmacies has been reported.26
The finding that a greater proportion of chain pharmacies
possessed a tobacco licence (97%) compared with non-chain
pharmacies (38%) is consistent with previous reports.20–23 27
For instance, Hickey and colleagues examined tobacco and phar-
macy licences in Iowa and found that chain pharmacies were
34 times more likely to sell tobacco products, compared with
independent pharmacies.27 Chain pharmacies likely follow a
corporate structure and may be less able to make decisions
regarding tobacco product sales within individual stores,
compared with independent pharmacies. Among the sample of
pharmacies contacted, only two chain pharmacies reported not
selling tobacco products.
Previous research has revealed a significant association
between tobacco retailer density and youth smoking.28 Further,
proximity to tobacco retailers has been shown to influence
smoking abstinence among smokers motivated to quit.29
Removal of tobacco sales from Massachusetts pharmacies,
which make up nearly 10% of tobacco retailers in the state,
might directly reduce the density and proximity of tobacco
retailers to youth and adult smokers. Therefore, potential
public health benefits may be realised through the adoption of
tobacco-free pharmacy policies. However, no studies to date
have investigated the impact of tobacco sales restrictions in
pharmacies on smoking behaviour and initiation. Further
research should also investigate pharmacists’ knowledge of
alternative tobacco products. Because these products are avail-
able for sale within pharmacies, pharmacists should be trained
in discussing the potential risks of these products.
Massachusetts has been a leader in implementing effective
tobacco control policies and has one of the nation’s lowest
smoking rates.30 31 Consequently, this study’s findings may
not be generalisable to the rest of the USA. Pharmacies which
declined to participate may have differed from the analytical
sample, creating a potential sampling bias. Further, the definition
used for chain pharmacy (five or more stores in Massachusetts)
may have resulted in some pharmacies being misclassified (eg,
national chain pharmacies being classified as non-chains). This
definition was used because it has been used elsewhere for enfor-
cing tobacco control policies.32 Finally, telephone interview data
were not independently verified. However, the survey strategy
used enabled the collection of data from a random sample of
pharmacies located throughout Massachusetts.
CONCLUSION
Since completion of this study, several additional communities
in Massachusetts have adopted tobacco-free pharmacy policies
(personal correspondence (AS), Municipal Tobacco Control
Technical Assistance Program). In Massachusetts, instituting
tobacco-free pharmacy laws would impact a majority of
pharmacies, resulting in the removal of a variety of tobacco
Figure 2 Availability of tobacco
products and NRT products in
Massachusetts pharmacies selling
tobacco.
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products from their shelves. Further, nearly one in ten tobacco
retailers would be eliminated by prohibiting tobacco sales in
pharmacies in Massachusetts statewide. Publicly available data,
such as pharmacy and tobacco retailer registration, can be used
to estimate the scope of state-level involvement of pharmacies
in the tobacco retail sector. These data from the USA contrast
markedly with the prevailing situation in most countries,
where voluntary or tobacco sales bans in pharmacies are the
norm. Indeed, one predicted future trend for tobacco control
may see pharmacies designated as the sole conveyor of tobacco
products, under a system of highly restricted sale.33 Until such
time, further research is needed to understand the impact on
smoking initiation and maintenance that new tobacco-free
pharmacy policies will have in jurisdictions in which they are
introduced.
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What this paper adds
▸ Despite a growing number of communities adopting tobacco-
free pharmacy policies, little is known regarding the scope of
pharmacy involvement in the tobacco market.
▸ This study found that tobacco-free pharmacy policies stand
to affect a majority of Massachusetts pharmacies and nearly
one in ten tobacco retailers. Further, a wide variety of
tobacco products, including cigarettes, cigars, little cigars/
cigarillos, moist snuff and pipe tobacco, are currently being
sold in pharmacies.
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